Xcel Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Xcel therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Xcel Therapeutics Today - Breaking & Trending Today

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) CEO Vimal Mehta Sells 126,014 Shares

BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Free Report) CEO Vimal Mehta sold 126,014 shares of the firm’s stock in a transaction on Tuesday, June 4th. The stock was sold at an average price of $1.63, for a total transaction of $205,402.82. Following the transaction, the chief executive officer now directly owns 7,811,515 shares of the […] ....

United States , Vimal Mehta , Tower Research Capital , Truist Financial Corp , Virtu Financial , Canaccord Genuity Group , Bioxcel Therapeutics Company Profile , Apollon Wealth Management , Bioxcel Therapeutics Inc , Bioxcel Therapeutics , Get Free Report , Xcel Therapeutics Trading Down , Xcel Therapeutics , Wealth Management , Financial Corp , Research Capital , Pennant Investors , Bioxcel Therapeutics Daily ,

Insider Selling: BioXcel Therapeutics, Inc. (NASDAQ:BTAI) CEO Sells 126,014 Shares of Stock

BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Free Report) CEO Vimal Mehta sold 126,014 shares of BioXcel Therapeutics stock in a transaction that occurred on Tuesday, June 4th. The stock was sold at an average price of $1.63, for a total transaction of $205,402.82. Following the transaction, the chief executive officer now directly owns 7,811,515 shares […] ....

United States , Vimal Mehta , Truist Financial Corp , Virtu Financial , Canaccord Genuity Group , York Mellon Corp , Bioxcel Therapeutics Inc , Apollon Wealth Management , Bioxcel Therapeutics , Get Free Report , Xcel Therapeutics Trading Down , Xcel Therapeutics , New York Mellon Corp , Financial Corp , Bioxcel Therapeutics Daily ,

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Short Interest Up 8.7% in May

BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Free Report) was the target of a significant growth in short interest in May. As of May 15th, there was short interest totalling 1,630,000 shares, a growth of 8.7% from the April 30th total of 1,500,000 shares. Based on an average daily trading volume, of 584,400 shares, the days-to-cover […] ....

United States , Canaccord Genuity Group , Apollon Wealth Management , Bioxcel Therapeutics Company Profile , Tower Research Capital , Virtu Financial , Vanguard Group Inc , Bioxcel Therapeutics Inc , Bioxcel Therapeutics , Get Free Report , Research Capital , Xcel Therapeutics , Genuity Group , Bioxcel Therapeutics Daily ,

BioXcel Therapeutics to Present at Jefferies Global Healthcare Conference

28.05.2024 - NEW HAVEN, Conn., May 28, 2024 (GLOBE NEWSWIRE) - BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, today announced . Seite 1 ....

New York , United States , Vimal Mehta , Vincentj Oneill , Product Development , Drug Administration , Bioxcel Therapeutics Inc , Xcel Therapeutics , Jefferies Global Healthcare Conference , Bioxcel Therapeutic , Executive Vice President , Bioxcel Therapeutics , Breakthrough Therapy , Fast Track ,

BioXcel Therapeutics Announces Oral and Poster Presentations at the 2024 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

BioXcel Therapeutics Announces Oral and Poster Presentations at the 2024 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

United States , Rob Risinger , American Society Of Clinical Psychopharmacology , Bioxcel Therapeutics Inc , Xcel Therapeutics , Chief Medical Officer , Clinical Psychopharmacology , Miami Beach ,